As of 2025-08-13, the Relative Valuation of Bioventus Inc (BVS) is (5.91) USD. This relative valuation is based on P/E multiples. With the latest stock price at 7.31 USD, the upside of Bioventus Inc based on Relative Valuation is -180.8%.
The range of the Relative Valuation is (5.02) - (8.04) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 11.5x - 24.4x | 14.4x |
| Forward P/E multiples | 13.0x - 20.9x | 16.3x |
| Fair Price | (5.02) - (8.04) | (5.91) |
| Upside | -168.6% - -210.0% | -180.8% |
| Date | P/E |
| 2025-08-12 | -19.00 |
| 2025-08-11 | -18.01 |
| 2025-08-08 | -17.98 |
| 2025-08-07 | -18.01 |
| 2025-08-06 | -18.94 |
| 2025-08-05 | -15.96 |
| 2025-08-04 | -16.42 |
| 2025-08-01 | -16.06 |
| 2025-07-31 | -16.94 |
| 2025-07-30 | -17.00 |
| 2025-07-29 | -17.00 |
| 2025-07-28 | -16.97 |
| 2025-07-25 | -17.07 |
| 2025-07-24 | -16.63 |
| 2025-07-23 | -16.81 |
| 2025-07-22 | -16.74 |
| 2025-07-21 | -16.37 |
| 2025-07-18 | -16.27 |
| 2025-07-17 | -16.87 |
| 2025-07-16 | -17.25 |
| 2025-07-15 | -17.15 |
| 2025-07-14 | -17.70 |
| 2025-07-11 | -18.11 |
| 2025-07-10 | -19.20 |
| 2025-07-09 | -19.02 |
| 2025-07-08 | -18.37 |
| 2025-07-07 | -17.72 |
| 2025-07-03 | -18.24 |
| 2025-07-02 | -17.80 |
| 2025-07-01 | -18.11 |
| 2025-06-30 | -17.20 |
| 2025-06-27 | -17.59 |
| 2025-06-26 | -17.31 |
| 2025-06-25 | -17.38 |
| 2025-06-24 | -17.57 |
| 2025-06-23 | -16.94 |
| 2025-06-20 | -17.02 |
| 2025-06-18 | -16.71 |
| 2025-06-17 | -16.50 |
| 2025-06-16 | -17.15 |
| 2025-06-13 | -17.20 |
| 2025-06-12 | -17.44 |
| 2025-06-11 | -17.44 |
| 2025-06-10 | -17.83 |
| 2025-06-09 | -17.46 |
| 2025-06-06 | -17.38 |
| 2025-06-05 | -16.92 |
| 2025-06-04 | -16.97 |
| 2025-06-03 | -17.31 |
| 2025-06-02 | -16.74 |